Effect of blood flow restriction low resistance exercise on hemodynamic for coronary artery disease patients: Randomized Control Trial
Keywords:Keyword: coronary artery disease, blood flow restriction low resistance exercises, hemodynamic.
Back ground: Coronary heart disease (CHD) is the leading cause of mortality. Although fewer individuals are dying from CHD, more people are living with the condition and may require assistance to manage their symptoms and prognosis. Objective: to determining the effectiveness of blood flow restriction low resistance exercise on the patients with coronary artery disease. Methodology: A randomized control trial that was performed on 100 patients referred for (cardiac rehabilitation unite, consultation) to the AL-Najaf Center for Cardiac Surgery and Cardiac Catheterization. Patients were selected through non probability (purposively) and were randomly assigned into two groups of (50) patients in each one. The study group have been exposed to blood flow low resistance restriction exercises by the researcher. The group that has not been exposed to blood flow low resistance restriction exercises by the researcher are considered the control group. the study started from period 9 th February 2023 to 6th July 2023.Results: The results of the study showed that there is a significant difference between the study group and the control group pre use the blood flow restriction low resistance exercise and post use the exercise. conclusion: The study stated that the patients in study group who received the blood flow restriction low resistance exercise had decrease in the (heart rate, and blood pressure and Spo2) compared to the control group. recommendation: recommend the use of blood flow restriction low resistance exercises on patients with coronary arteries disease, because the study has proven that the exercise is effective and responds to hemodynamic.
How to Cite
Copyright (c) 2023 Zaman G. Ghazal Al-Mimar, Mohammed A. AL Kareem, Husham K. Mohammed
This work is licensed under a Creative Commons Attribution 4.0 International License.